BioSpace presented the NextGen Bio “Class of 2021,” a list of up-and-coming life sciences companies in North America that recently launched.
The IQVIA Institute for Human Data Science found in its latest report – Global Oncology Trends 2019: Therapeutics, Clinical Development and Health System Implications – that in 2018 a record-setting 15 new active substance oncology treatments with 17 indications, including one tissue-agnostic therapy, launched in the U.S.
Germany-based Evotec SE followed up a string of collaborations with pharma companies with the $90 million acquisition of Bill & Melinda Gates Foundation-backed Just Biotherapeutics Inc.
Lilly inked a deal with Eddingpharm for the rights to two legacy antibiotic medicines and a manufacturing facility in Suzhou, China.
Gilead Sciences and its cell therapy subsidiary Kite Pharma agreed to acquire Cell Design Labs.
VANCOUVER, British Columbia–(BUSINESS WIRE)–Zymeworks Inc. today announced that it has entered into a collaboration and license agreement with GlaxoSmithKline (GSK) for the research, development, and commercialization of novel Fc-engineered monoclonal […]
